文献速递神经肿瘤

治疗性休眠延迟胶质瘤术后复发:局部低温的过去、现在与前景

Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia.
PubMed 文献 · J Neurooncol · 2017-05-17

手术是胶质瘤一线治疗,但多数患者仍因切除缘局部复发死亡。手术相关脑损伤反应被残留胶质瘤细胞劫持参与局部再生。作者提出在切除缘诱导治疗性低温以延迟复发,并认为未来在于植入式局部微冷却装置,需开展临床前与临床策略评估。

要点

  • 胶质瘤术后切除缘的止血、血管新生、反应性胶质增生和炎症反应可被残留肿瘤细胞劫持参与局部复发。
  • 在切除缘诱导治疗性低温可能通过限制细胞增殖、打断炎症与复发之间的病理联系及限制肿瘤生态系统功能异质性后果来延迟局部复发。
  • 目前临床用于卒中的全身冷却方法可能不足以治疗切除缘,未来在于类似癫痫治疗中正在开发的植入式局部微冷却装置。

核心结论

  • 在切除缘诱导治疗性低温可能通过限制细胞增殖、打断炎症与胶质瘤复发的病理联系及限制肿瘤生态系统固有的功能异质性和复杂性后果来延迟胶质瘤局部复发。
  • 目前临床用于卒中的全身冷却方法可能不足以治疗切除缘,未来在于类似癫痫治疗中正在开发的植入式局部微冷却装置。
  • 必须实施评估局部低温的临床前和临床策略以预防切除缘胶质瘤复发,将切除缘置于休眠状态可能提供期待已久的治疗突破。

研究设计与样本

  • 原文为综述,讨论局部低温延迟胶质瘤术后复发的过去、现在与前景。

主要发现

  • 手术相关脑损伤反应被残留胶质瘤细胞劫持并参与切除缘局部肿瘤组织再生。
  • 诱导治疗性低温在脑内长期用于治疗意外创伤性脑损伤所致的神经炎症和水肿等继发性损害。
  • 有令人信服的证据提示在切除缘诱导治疗性低温可通过限制细胞增殖、打断炎症与胶质瘤复发的病理联系及限制肿瘤生态系统固有的功能异质性和复杂性后果来延迟局部复发。

临床怎么用

  • 作者认为目前临床用于卒中的全身冷却方法可能不足以治疗切除缘,未来在于类似癫痫治疗中正在开发的植入式局部微冷却装置。
  • 作者提出必须实施评估局部低温的临床前和临床策略以预防切除缘胶质瘤复发。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Surgery precedes both radiotherapy and chemotherapy as the first-line therapy for glioma. However, despite multimodal treatment, most glioma patients die from local recurrence in the resection margin. Glioma surgery is inherently lesional, and the response of brain tissue to surgery includes hemostasis, angiogenesis, reactive gliosis and inflammation. Unfortunately, these processes are also associated with tumorigenic side-effects. An increasing amount of evidence indicates that the response to a surgery-related brain injury is hijacked by residual glioma cells and participates in the local regeneration of tumor tissues at the resection margin. Inducing therapeutic hypothermia in the brain has long been used to treat the secondary damage, such as neuroinflammation and edema, that are caused by accidental traumatic brain injuries. There is compelling evidence to suggest that inducing therapeutic hypothermia at the resection margin would delay the local recurrence of glioma by (i) limiting cell proliferation, (ii) disrupting the pathological connection between inflammation and glioma recurrence, and (iii) limiting the consequences of the functional heterogeneity and complexity inherent to the tumor ecosystem. While the global whole-body cooling methods that are currently used to treat stroke in clinical practice may not adequately treat the resection margin, the future lies in implantable focal microcooling devices similar to those under development for the treatment of epilepsy. Preclinical and clinical strategies to evaluate focal hypothermia must be implemented to prevent glioma recurrence in the resection margin. Placing the resection margin in a state of hibernation may potentially provide such a long-awaited therapeutic breakthrough.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Wion D. Therapeutic dormancy to delay postsurgical glioma recurrence: the past, present and promise of focal hypothermia. J Neurooncol. 2017. PMID: 28516343. doi:10.1007/s11060-017-2471-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。